References
- Aitchinson M, Mufti G R, Farrel J, Paterson P J, Scott R. Granulomatous orchitis. Review of 15 cases. Br J Urol 1990; 66: 312–314
- de Boer L C, Steerenberg P A, van der Meiden A PM, et al. Impaired immuneresponse by isoniazid treatment during intravesical BCG administration in the guinea pig. J Urol 1992; 142: 1577–1582
- Böhle A, Thanhauser A, Ulmer A J, et al. On the mode of action of intravesical bacillus Calmette-Guerin: in vitro characterization of BCG activated killer cells. Urol Res 1994; 22: 185–190
- Israel-Biet D, Venet A, Sandron D, Ziza J M, Chretien J. Pulmonary complications of intravesical bacille Calmette-Guerin immunotherapy. Am Rev Respir Dis 1987; 135: 763–765
- Kamat M R, Kulkarni J N, Tongaonkar H B, Dalai A V. Intravesical bacillus Calmette-Guerin for superficial bladder cancer: experience with Danish 1331 strain. J Urol 1994; 152: 1424–1428
- Lamm D L. Complications of bacillus Calmette-Guerin immunotherapy. Urol Clin North Am 1992; 19: 565–572
- van der Meiden A PM, Sterenberg P A, de Jong W H, Debruyne F MJ. Intravesical bacillus Calmette-Guerin treatment of superficial bladder cancer: results after 15 years of experience. Anticancer Res 1991; 11: 1253–1258
- Morales A, Eidinger D, Bruce A W. Intracavitary bacillus Calmette-Guérin in the treatment of superficial bladder tumors. J Urol 1976; 116: 180–183
- Morales A, Nickel J C. Immunotherapy for superficial bladder cancer. A developmental and clinical overview. Urol Clin North Am 1992; 19: 549–556
- Stanisic T H, Brewer M L, Graham A R. Intravesical bacillus Calmette-Guérin therapy and associated granulomatous renal masses. J Urol 1986; 135: 356–358
- Stassar M JJG, Vegt P DJ, Steerenberg P A, et al. Effects of isoniazid (INH) on the BCG-induced local immune response after intravesical BCG therapy for superficial bladder cancer. Urol Res 1994; 22: 177–184